Concepedia

Jordan Berlin

JB

Statistics

Publications

212

Citations

36.9K

H-Index

69

Active since

1980

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

Vanderbilt-Ingram Cancer Center

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Jordan Berlin is an author at Vanderbilt University specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1980–2025

212

Publications

212

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

, , +15

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

, , +17

Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children

Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

, , +16

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Luis A. Díaz, Richard T. Williams, Jian Wu et al. · Nature · 2012 · 1.7K citations · Full text

, , +16

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

David S. Hong, Steven G. DuBois, Shivaani Kummar et al. · The Lancet Oncology · 2020 · 994 citations · Full text

, , +14

1–5 of 212